Characterization of resistance to newer antimicrobials among carbapenem-resistant Klebsiella pneumoniae in the post-acute-care setting.

Helen L Zhang Kyle J Gontjes Jennifer H HanKevin AlbyZena LappEvan SnitkinEllie J C GoldsteinSean MuldoonPam TolomeoEbbing Lautenbach

Published in: Infection control and hospital epidemiology (2022)

We assessed susceptibility patterns to newer antimicrobial agents among clinical carbapenem-resistant Klebsiella pneumoniae (CRKP) isolates from patients in long-term acute-care hospitals (LTACHs) from 2014 to 2015. Meropenem-vaborbactam and imipenem-relebactam nonsusceptibility were observed among 9.9% and 9.1% of isolates, respectively. Nonsusceptibility to ceftazidime-avibactam (1.1%) and plazomicin (0.8%) were uncommon.

Keyphrases

klebsiella pneumoniae
acute care
multidrug resistant
escherichia coli
gram negative
end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
peritoneal dialysis
prognostic factors